In GEMMs, a study by Olive et al. demonstrated that the use of SHH inhibitors against smoothened (SMO) leads to the depletion of pancreatic tumor stroma and additional treatment with gemcitabine results in an increased number of apoptotic tumor cells and prolonged patient survival [252]. This evidence concerns the gene SHH and pancreatic neoplasm.